Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(rifAXIMin)
1,239 results
  • Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report. [Case Reports]
  • OAOpen Access Maced J Med Sci 2019 May 31; 7(10):1669-1671
  • Chowdhury AR, Marcus EN
  • CONCLUSIONS: Though uncommon, hepatic encephalopathy should be considered in patients presenting with convulsions, especially if there is a known history of liver disease. Until the underlying liver issues are addressed, patients may not respond to traditional anti-convulsant therapy for their seizures.
  • Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview. [Review]
  • JIJ Infect 2019; 79(2):75-94
  • Kakoullis L, Papachristodoulou E, … Panos G
  • CONCLUSIONS: It appears that, while some antibiotics such as b-lactams and TMP/SMX may be detrimental, others appear to be safe and can prevent the development of HUS. Of note, fosfomycin appears to be the antibiotic with the most positive results from clinical studies, and may be able to avert HUS development, especially if administered within the first two or three days from diarrhoea onset. Fluoroquinolones have also shown positive outcomes in clinical studies, despite demonstrating unfavourable results in in vitro studies. Other agents, such as colistin, gentamycin and rifamycins, have shown promising results in in vitro studies and require further evaluation.
New Search Next